Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC

Hepatocellular carcinoma (HCC) is one of the primary types of cancer that claims many lives worldwide, and its incidence continues to increase. Conventional therapies against liver cancer are inadequate, and the pathogenesis of HCC remains unclear. Thus, not only are more effective therapies to trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yulong, Song, Qingzhu, Zhang, Fenglan, Yuan, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668352/
https://www.ncbi.nlm.nih.gov/pubmed/34912753
http://dx.doi.org/10.1155/2021/5601678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668352/
https://www.ncbi.nlm.nih.gov/pubmed/34912753
http://dx.doi.org/10.1155/2021/5601678

Ejemplares similares